Table 3 Clinical response of advanced colorectal adenocarcinoma patients to gemcitabine, oxaliplatin, and infusional levo-folinic acid and 5-fluorouracil (GOLF) multidrug chemotherapy

From: A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma

Number

PD

CR

PR

SD

NE

289

6

3

9

10

1

100%

20.7%

10.3%

31.2%

34.4%

3.4%

  1. PD=progressive disease; CR=complete response; PR=partial response; SD=stable disease; NE=nonevaluable for response for early death.
  2. The time to progression was 7.26 months (95% of CI 6.88–12.62).
  3. The overall survival was 22 months (95% CI 12.6–26.5).
Back to article page